Month: April 2024

On 15. April 2024, the addendum to the design-build contract between UAB Merko Statyba, part of AS Merko Ehitus group, and North Atlantic Treaty Organization (NATO) Support and Procurement Agency entered into force for additional works on the construction of new infrastructures of the training center in Pabrade, Lithuania. The value of additional works exceeds EUR 20 million, plus the applicable value added tax. The actual value is determined after adjustment with the construction price index of the respective periods. The construction works are scheduled to be completed by 2026. UAB Merko Statyba (merko.lt) is Lithuanian construction company, which offers construction services in the fields of general construction and residential construction. Additional information: UAB Merko Statyba, Construction Director Mr. Jaanus Rästas, phone: +370 6875 0680. ...

PRESS RELEASE Regulated Information Antwerp, Belgium, 16 April 2024 (7.00 a.m. CET) VGP NV (‘VGP’) and Deka Immobilien, one of the largest globally active real estate investment companies in Europe, today announced the signing of the second closing between VGP and their 50:50 joint venture, RED (The ‘Fifth Joint Venture’). The transaction comprises two logistics buildings and a multi-storey car park which were developed in parks that have already transferred to the joint venture in the first closing. At the time of the first closing these assets were still under construction. The two buildings are located in VGP Park Giessen Am Alten Flughafen and VGP Park Berlin – Oberkrämer and are fully leased to Zalando (Giessen), Toussaint and BTG International Spedition (Oberkrämer). The transaction with RED will be the 2nd closing...

ADHERE data show VYVGART® Hytrulo has potential to be first advancement for CIDP patients in 30 years Real-world data demonstrate gMG patients able to significantly reduce steroid use over first six months of initiating VYVGART® treatment April 16, 2024 – 7:00am CET Amsterdam, the Netherlands – argenx SE (Euronext & Nasdaq: ARGX), a global immunology company committed to improving the lives of people suffering from severe autoimmune diseases, today announced that data from its Phase 3 ADHERE trial evaluating VYVGART Hytrulo (efgartigimod alfa and hyaluronidase-qvfc) in patients with chronic inflammatory demyelinating polyneuropathy (CIDP) were presented for the first time to the medical community during the Clinical Trials Plenary Session at the American Academy of Neurology (AAN) Annual Meeting in Denver, CO. argenx also highlighted...

SANTA MONICA, Calif., April 15, 2024 (GLOBE NEWSWIRE) — JAKKS Pacific, Inc. (NASDAQ: JAKK) will announce its first quarter 2024 financial results on Wednesday, April 24, 2024 after the close of the stock market. The Company will hold a teleconference and webcast to discuss the results, and may also discuss future plans and prospects. JAKKS Pacific, Inc. invites analysts, investors and media to listen to the teleconference scheduled for 5:00 p.m. ET / 2:00 p.m. PT on April 24, 2024. A live webcast of the call will be available on the “Investor Relations” page of the Company’s website at www.jakks.com/investors. To access the call by phone, please go to this link (1Q24 Registration link), and you will be provided with dial-in details. To avoid delays, we encourage participants to dial into the conference call fifteen minutes ahead...

Ad Hoc Announcement Pursuant to Article 53 of the SIX Exchange Regulation Listing Rules STRONG START TO THE YEAR: RECORD SALES AND HIGH, DOUBLE-DIGIT GROWTH IN THE FIRST QUARTERHigh, double-digit growth of +20.1% in local currencies Q1 sales of CHF 2,648.0 million (+13.8% in CHF) Acquisition effect of 19.9% Negative currency effect of –6.3% Acquisition of Kwik Bond in the USA Outlook for fiscal 2024 confirmedSales growth in local currencies of 6–9% Over-proportional increase in EBITDA Confirmation of 2028 strategic targets for sustainable, profitable growthSika can look back on a successful start to the current financial year and increased its sales in local currencies by 20.1% in the first quarter of 2024. A high acquisition effect of 19.9% contributed to the first-quarter new record sales. This was mostly accounted for by the...

Provides Update on Annual Filings Timing SAN DIEGO and TORONTO, April 15, 2024 (GLOBE NEWSWIRE) — StateHouse Holdings Inc. (“StateHouse” or the “Company”) (CSE: STHZ) (OTCQB: STHZF), a California-focused, vertically integrated cannabis company, today announced that Felicia Snyder has been appointed as independent Chair of the Board of Directors of the Company (the “Board”) effective April 14th, 2024. In connection with the appointment, Matthew K. Hawkins has stepped down from the Board effective April 12th, 2024, to focus on capital raising activities ahead of Entourage Effect Capital’s upcoming fourth fund launch. “Felicia has provided a wealth of strategic guidance and leadership as a Board Member and we are thrilled to see her take on the role of Chair,” said Edward Schmults, Chief Executive Officer and Director of StateHouse....

VANCOUVER, British Columbia, April 15, 2024 (GLOBE NEWSWIRE) — Fortuna Silver Mines Inc. (NYSE: FSM) (TSX: FVI) is pleased to provide an update on its Yessi vein exploration program at the San Jose Mine in Mexico. Paul Weedon, Senior Vice President of Exploration, commented, “Drilling on the Yessi vein, since the initial discovery hole in August 2023, has continued to establish a well-defined system, with recent results such as 1,327 g/t Ag Eq over an estimated true width of 3.0 meters from 604.85 meters in SJO-1444 and 1,036 g/t Ag Eq over an estimated true width of 8.1 meters including 2,910 g/t Ag Eq in SJO-1460 highlighting the potential for high-grade shoots. In addition, wide intervals such as the 179 g/t Ag Eq over an estimated true width of 17.5 meters in SJO-1455A highlight the potential for broad zones of mineralization”. Yessi...

DENVER, April 15, 2024 (GLOBE NEWSWIRE) — ArrowMark Financial Corp., (NASDAQ: BANX) (“ArrowMark Financial”), today announced that BANX’s estimated and unaudited Net Asset Value (“NAV”) as of March 28, 2024, was $21.24. This estimated NAV is not a comprehensive statement of our financial condition or results for the month ended March 28, 2024. About ArrowMark Financial Corp. ArrowMark Financial Corp. is an SEC registered non-diversified, closed-end fund listed on the NASDAQ Global Select Market under the symbol “BANX.” Its investment objective is to provide shareholders with current income. BANX pursues its objective by investing primarily in regulatory capital securities of financial institutions. BANX is managed by ArrowMark Asset Management, LLC. To learn more, visit ir.arrowmarkfinancialcorp.com, or contact Destra...